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Background: Human Immunodeficiency Virus Type 1 (HIV-1) viral load testing at regular intervals is an integral
component of disease management in Acquired Immunodeficiency Syndrome (AIDS) patients. The need in
countries like India is therefore an assay that is not only economical but efficient and highly specific for HIV-1 sub
type C virus. This study reports a SYBR Green-based HIV-1 real time PCR assay for viral load testing and is designed
for enhanced specificity towards HIV-1 sub type C viruses prevalent in India.
Results: Linear regression of the observed and reference concentration of standards used in this study generated a
correlation coefficient of 0.998 (p < 0.001). Lower limit of detection of the test protocol was 50 copies/ml of plasma.
The assay demonstrated 100% specificity when tested with negative control sera. The Spearman coefficient of the
reported assay with an US-FDA approved, Taqman probe-based commercial kit was found to be 0.997. No significant
difference in viral load was detected when the SYBR Green based assay was used to test infected plasma stored at −20°C
and room temperature for 7 days respectively (Wilcoxon signed rank test, p = 0.105). In a comparative study on 90
pretested HIV-1 positive samples with viral loads ranging from 5,000–25,000 HIV-1 RNA copies/ml and between
two commercial assays it was found that the later failed to amplify in 13.33% and 10% samples respectively while
in 7.77% and 4.44% samples the copy number values were reduced by >0.5 log value, a figure that is considered
clinically significant by physicians.
Conclusion: The HIV-1 viral load assay reported in this study was found to be robust, reliable, economical and
effective in resource limited settings such as those existing in India. PCR probes specially designed from HIV-1
Subtype C-specific nucleotide sequences originating from India imparted specificity towards such isolates and
demonstrated superior results when compared to two similar commercial assays widely used in India.
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At present estimating HIV-1 RNA plasma concentration
is the standard of care in monitoring the progression of
HIV/AIDS and is believed to have clinically useful prog-
nostic value [1,2]. Three different commercial assays
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unless otherwise stated.(Roche Molecular Systems, USA)] presently dominate
the HIV-1 viral load testing market but are prohibitively
expensive [3].
Real time PCR technology is currently considered the
gold standard for HIV-1 viral load detection because of
its high assay specificity, sensitivity and wide linear range
of detection [4]. TaqMan chemistry is widely popular
and accepted method but in order to develop this on
real time PCR platform for quantification of HIV-1 viral
RNA, three conserved regions within the viral genome
are required all in close proximity which is often difficult
due to the heterogenic genomic structure of HIV-1. Theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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istry based commercial assay is mostly encountered in
countries where non B subtype of HIV-1 is prevalent
because these assays are widely validated in USA and
Europe where HIV-1 subtype B dominates [3,5]. In addition
to the TaqMan chemistry, SYBR Green chemistry based
real time PCR is also widely used for HIV-1 viral RNA
quantification assays.
In this study, we report a real time RT-PCR assay spe-
cifically optimized for HIV-1 C subtype that uses SYBR
Green chemistry for quantitative detection of HIV-1
viral RNA in human plasma. The assay is designed to
target a conserved region within the gag gene of the viral
genome and is less expensive compared to those which em-
ploy dual-labeled TaqMan probes. The protocol gave con-
sistent results across a wide range of clinical samples.
Results
Linear range, detection limit and inter-assay precision
The linearity of the assay was determined using refer-
ence standards constructed specifically for this assay by
using a recombinant plasmid harboring the amplified
gag gene fragment as insert. Linear regression of the ob-
served and reference concentrations yielded a correl-
ation coefficient of 0.998 (p < 0.001). A standard curve
was generated by plotting the threshold cycles of refer-
ence standards versus their log concentrations (Figure 1).
The dissociation curve of all reference standards showed
a melting temperature of 85.5°C (Figure 2).
In order to compute the detection limit samples with
known viral load in the range of 10 to 500 HIV-1 RNA
copies/ml were analyzed. The results showed detectable
amplification in 5 (25%) of the replicates for standard
having 10 HIV-1 RNA copies/ml, in 10 (50%) of the rep-
licates for those having 30 HIV-1 RNA copies/ml, and
20 (100%) having 50, 100 and 500 copies/ml of HIV-1





















Figure 1 Standard curve for quantification of HIV-1 viral load.
Log concentration of serial diluted reference standards plotted
against their corresponding Threshold Cycles.diagram where the log concentrations are compared
with their corresponding threshold cycles (Figure 3).
From this analysis, the lower limit of the assay was fixed
at 50 copies/ml of HIV-1 RNA.
In order to evaluate the inter-assay precision of the
test protocol the reference panel comprising of 25 sam-
ples with known HIV-1 viral load were tested in tripli-
cates through 10 independent experiments. Statistical
analysis of the data for standard deviation (SD) and coef-
ficient of variation are shown in Table 1. The coefficient
of variation was found to increase as the reference viral
load approached detection limit of the assay.
Sensitivity and specificity of the in-house HIV-I RT PCR
assay
Clinical sensitivity of the assay was determined using
samples from the reference panel. All 25 samples were
found to be positive using the in-house SYBR Green RT
PCR assay indicating 100% sensitivity. The specificity of
the assay was also found to be 100% since none of the
samples showed any detectable amplification from our
reference panel of HIV-1-negative samples (Figure 4).
This was further confirmed by analyzing the melting
temperature profile of the amplicons using dissociation
curve analysis. No significant fluorescent signals were
detected from any non-specific amplification including
primer dimers.
Comparison of viral load measurements using the in-house
and the US-FDA approved artus HIV-1 RG RT-PCR kit
Viral load of 100 HIV-1 sero-positive samples was
determined both by a commercially available US FDA-
approved artus HIV-1 RG RT-PCR kit (Qiagen, Germany)
as well as the SYBR Green RT PCR assay described in this
study. The log concentration of HIV-1 RNA copies/ml of
samples were compared by plotting results obtained using
the present study protocol with those obtained using artus
HIV-1 RG RT-PCR kit (Figure 5). The spearman coefficient
of the in house assay with that of artus HIV-1 RG RT-PCR
kit was found to be 0.997.
Comparison of sensitivity with two commercial HIV-1 RNA
detection assays
The detection limit of HIV RNA Real-Quant (Sacace Bio-
technologies S.r.l, Italy) and HIV-1 Real Time RT PCR kit
(Life River, Shanghai ZJ Biotech, China) are 500 and 1,000
HIV-1 RNA copies/ml respectively. Out of the 90 samples
whose viral load varied between 5000 - 25,000 HIV-1
RNA copies/ml as determined by artus HIV-1 RG RT-
PCR kit (Qiagen, Germany), 12 (13.33%) and 9 (10.0%)
samples fail to show any detectable amplification when
tested using HIV RNA Real-TM Quant (Sacace
Biotechnologies S.r.l, Italy) and HIV-1 Real Time RT PCR
kit (Life River, Shanghai ZJ Biotech, China) respectively.
Figure 2 Dissociation curve of the HIV-1 reference standards. The negative first derivative of fluorescent signal (Y-axis) was plotted against
Temperature (X-axis).
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tion of viral load at a value that is greater than 0.5 log when
compared with reference panel results. All the above men-
tioned samples had comparable results when tested using
the protocol described in this study as shown in Table 1.
Effect of ambient temperature on stability of HIV-1 RNA
Effect of storage of plasma at room temperature was
studied by analyzing 10 plasma samples each stored inFigure 3 Bar diagram used for finding the detection limit of the
their corresponding Threshold Cycles. Series 1: Threshold Cycles; Seri
copies/ml; CTN30: 30 HIV-1 RNA copies/ml; CTN50: 50 HIV-1 RNA cop
RNA copies/ml.(1) -20°C freezer and (2) room temperature (25°C) for
7 days. These samples were subjected to viral load test-
ing and each reaction was performed in triplicate. Re-
sults indicate a w- value of 11.5, mean difference of 1.01,
sum of positive ranks equaling to 43.5 and sum of nega-
tive ranks equaling to 11.5 respectively. As the critical
value of w for n = 10 (p ≤ 0.05) was 8, the result was not
significant meaning that there was no significant differ-
ence in viral load detected in both the groups (Wilcoxonassay. Log concentration of the dilution series plotted with
es 2: Log concentration of viral load; CTN10: 10 HIV-1 RNA
ies/ml; CTN100: 100 HIV-1 RNA copies/ml; CTN500: 500 HIV-1
Table 1 Precision of the SYBR Green Real time PCR assay











52 50 1.65 0.0325
124 120 3.06 0.0251
344 345 0.47 0.0014
871 863 5.42 0.0063
1,235 1,250 10.14 0.0082
16,383 16,358 17.68 0.0011
267,816 267,098 507.70 0.0019
31,293 31,299 4.48 0.0001
541 534 4.71 0.0088
1,476 1,466 6.60 0.0045
4,572 4,555 12.26 0.0027
2571,210 2569,050 1,526.88 0.0006
76 89 9.43 0.1145
43,110 43,135 18.15 0.0004
5,447 5,414 23.10 0.0043
21,312 21,393 57.28 0.0027
96 94 1.65 0.0174
635,469 635,592 86.97 0.0001
626 620 4.48 0.0072
54,886 54,853 23.81 0.0004
8,742 8,781 27.58 0.0031
917,838 917,648 133.88 0.0001
74,511 74,552 29.23 0.0004
944 965 15.32 0.0161
9,648 9,984 237.82 0.0242
The standard deviation and the coefficient of variation were determined using
data from 10 independent experiments.
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whisker plot in Figure 6 show differences between me-
dians (DBM), over all visible spread (OVS) and DBM as
a percentage of OVS within the two groups equaling to
0.013, 1.114 and 1.17% respectively indicating no signifi-
cant difference between the two data sets.
Discussion
At present SYBR Green chemistry based real time PCR
is widely used for development of sensitive and econom-
ical quantitative PCR assays due to its competitive per-
formance when compared to TaqMan chemistry based
counterpart tests. In this study we described a SYBR
Green chemistry based sensitive real time PCR assay for
quantitative detection of HIV-1 viral load in human
plasma samples.
Two assay panels were created for the study. The ref-
erence study panel comprised of 25 HIV-1 sero-positivesamples with reference viral load assigned to them using
artus HIV-1 RG RT-PCR kit (Qiagen, Germany) and an
equal number of samples from healthy individuals. This
panel was primarily used for development of the assay.
The clinical study panel on the other hand was a sec-
ondary one comprising of 100 samples and was used to
evaluate the performance of the assay. Reference viral
load values were also assigned to this panel using artus
HIV-1 RG RT-PCR kit (Qiagen, Germany).
Most commercial HIV-1 viral load assays are designed
and optimized for the detection of viruses found in North
America and Europe. As a result, these assays either
under-quantify or fail to amplify some of the HIV-1 non-B
subtypes [6-8]. This observation motivated us to identify
the gag gene from Indian subtype C HIV-1 viruses as the
target to develop this SYBR Green chemistry based HIV-1
viral load estimation assay. The linearity of our assay
ranged from 50 HIV-1 RNA copies to 107 HIV-1 RNA
copies/ml of plasma sample and had a lower limit of de-
tection of 50 HIV-1 RNA copies/ml.
The normalized measure of dispersion of the probabil-
ity distribution of data generated from inter assay preci-
sion testing and expressed as coefficient of variation was
found to increase as the values came closer to the detec-
tion limit. This was found to be acceptable since the lin-
ear range of detection was wide and at par with standard
quantitative real time PCR assays [9-11].
The sensitivity of the assay was found to be 100%. No
amplification in 25 clinical samples from HIV-1 sero
negative reference panel indicated 100% specificity. This
finding was further consolidated by dissociation curve
analysis of all the sero positive reference panel samples.
Sharp peaks at 85.5°C were detected in all sero positive
reference panel samples and was absent in samples from
healthy individuals. The results obtained from clinical
study panel indicated a high level of concordance be-
tween the viral loads generated using the commercial kit
and the assay described in this study.
The poor sensitivity of two commercial assays [HIV
RNA Real-TM Quant (Sacace Biotechnologies S.r.l, Italy)
and HIV-1 Real Time RT PCR kit (Life River, Shanghai
ZJ Biotech, China) respectively] shown in this study may
be due to presence of nucleotide mismatches within the
primer and probe binding regions of HIV-1 genome. We
believe that suboptimal attention towards HIV-1 subtype
C specific sequences originating from India was the pri-
mary reason for such results. This finding is in line with
data presented by Drexler et al. which demonstrated that
HIV-1 positive samples which were reported negative by
three commercial assays were shown to have a HIV-1
viral load of >5,000 copies/ml when tested using a home
brew real time PCR protocol [7].
To evaluate the performance of the assay in a resource
limited setting we used the Wilcoxon signed-rank test
Figure 4 Bar diagram showing sensitivity and specificity of the assay. Sero-positive reference panel represented by DBL001 - DBLO25.
Amplification of all samples in this panel indicates 100% sensitivity. Sero-negative reference panel represented by DBN001 – DBN025. No amplification in
all samples in this panel indicates 100% specificity.
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statistical hypothesis test to compare the two related
samples (plasma samples stored in −20°C and at room
temperature respectively) and ascertain whether their
population mean ranks differed. Results indicated that
there were no significant differences in viral loads detected
in both the groups (Wilcoxon signed rank test, p = 0.105)
thus confirming the conclusions drawn from similar stud-
ies undertaken elsewhere [12]. In resource limiting setting
like India cold chain facility is not always available for
transportation of plasma samples from collection centers
to the reference laboratories. Stability of the samples at
ambient temperature is therefore important for proper
clinical management of the patients.Figure 5 Correlation of viral loads as determined by artus HIV-
1 RG RT-PCR kit and Present Study.Conclusions
There has been a significant increase in sensitivity of
HIV-1 RNA quantification due to systematic involve-
ment of advanced molecular techniques over the years.
However, enhanced cost and demand for greater reagent
and instrument sophistication is a necessary evil that
needs to be traded off to achieve high level of accuracy
and consistency. This is therefore a compelling reason
for exploring areas where economy and ease of work
can be linked to accuracy, sensitivity and specificity in
HIV-1 RNA quantification. To address these issues we
developed and evaluated the performance of SYBR
Green chemistry based HIV-1 viral load detection assay.
The significance of this study is high for a developing
country like India which has a high rate of HIV-1 infec-
tion. Some commercial assays originating from Europe
and China with poor attention to India-specific HIV-1
Subtype C genome sequences generated sub optimal
data in our study and therefore carry a risk of generating
error prone data with potential to mislead therapeutic
decisions. In these contexts the assay described in this
study specifically designed for Indian Subtype C viruses
is useful, economical and reliable for routine monitoring
of HIV-1 viral load in resource limited settings.
Methods
Clinical sample collection and processing
The reference panel comprised of blood samples col-
lected from 25 each of HIV-1 sero-positive (drug naïve)
and sero-negative (with no AIDS related risk factors)
individuals from India in K2-EDTA vacutainer tubes
(Becton Dickinson, San Diego, California, USA) after
obtaining written consent from the donors. The status
Figure 6 Comparison of viral load from 10 plasma samples
after storage at (X) -20°C degree and (Y) room temperature
(25°C) for 7 days prior to SYBR Green Real Time PCR assay
presented in a box and whisker plot.
Table 2 Characteristics of reference study panel
Sero positive reference panel (n = 25)
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assay (J. Mitra & Co. Ltd., New Delhi, India) (b) multiple
enzyme-linked immunosorbent assays (Biochem Immu-
nosystems, Montreal, Canada) and (c) western blot ana-
lysis (LAV Blot HIV-1, Bio- Rad, France). The viral load
for each of these samples was determined using a US
FDA-approved kit (artus HIV-1 RG RT-PCR kit; Qiagen,
Germany) and used as reference concentration.
Plasma were separated from the blood samples within
4 hours of collection and stored in a −20°C freezer. De-
tails of the study participants are described in Table 2.
The clinical study panel comprised of blood samples col-
lected from 100 HIV-1 sero-positive individuals. The viral
load for each of these samples was determined using a US
FDA-approved kit (artus HIV-1 RG RT-PCR kit; Qiagen,
Germany) and used for analysis and comparison.
The study program was duly approved by a bio-safety
and bio-ethics committee (Approval number SNGL/
2012/GY06) overseeing ethical aspect of such research
programs within the organization.Sero negative reference panel (n = 25)
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In order to avoid primer mismatch the most conserved
region of HIV-1 gag gene was chosen for designing of
the oligonucleotide primers. This region was identified
by analyzing several full length HIV-1 gag gene nucleo-
tide sequences submitted from India and obtained from
NCBI GenBank database (www.ncbi.nlm.nih.gov/gen-
bank) [13]. The sequences were aligned with the help of
multiple sequence alignment program ClustalW v.2 [14]
and conserved regions identified were used to manually
design PCR primers. Five different sets of forward and
reverse primers were designed, their reaction kinetics
as well as self-complimentarity checked using Primer
Express 3.0 program (Life Technologies, USA) and ex-
perimentally evaluated for their efficiency in amplifying
target DNA.
Construction of reference standards
For construction of reference standards, the HIV-1 gag
gene PCR fragment generated using the newly designed
PCR primers was cloned in the pCR4-TOPO vector (Life
Technologies. USA) following manufacturer’s instruc-
tions. The recombinant plasmid was purified and iden-
tity of the cloned insert confirmed by double strand
DNA sequencing using the BigDye Terminator v3.1
Cycle Sequencing Kit and ABI PRISM® 3500 Dx Genetic
Analyzer (Applied Biosystems, USA).
In order to generate quantization standard, the recom-
binant plasmid was serial diluted and calibrated against
reference standards of the US FDA approved artus HIV-
1 RG RT-PCR kit (Qiagen, Germany). A seven dilution
series of the reference standard was prepared with copy
numbers as follows: 101, 102, 103, 104, 105, 106 and 107
HIV-1 viral RNA copies/ml.
RNA extraction and reverse transcription–real time PCR
HIV-1 RNA was extracted from plasma samples using a
QIAamp Viral RNA mini kit according to manufacturer’s
instructions (Qiagen, Germany). SYBR Green I - based
one-step real time quantitative RT-PCR amplification was
performed using a StepOne Plus Real Time PCR System
(Applied Biosystems, USA). Fifty μL of a reaction mixture
comprised of 25 μL of 2X QuantiFast SYBR Green RT-PCR
master mix (Qiagen, Germany) which contained HotStarTaq
DNA Polymerase, 0.5 μL 100X QuantiFast RT Mix, 20 μL
of RNA and each primers (forward and reverse) at a final
concentration of 5 pmoles per reaction.
The nucleotide sequence of the primers used in this study
is as follows: 5′- ACATCAAGCAGCCATGCAAAT - 3′
(forward) and 5′- TACTAGTAGTTCCTGCTATGTC - 3′
(reverse). ROX dye was used as a passive reference to
normalize fluorescent signals. The thermal cycling profile
comprised of 30 minutes of reverse transcription at 45°C,
5 minutes of heating at 95°C to activate HotStart Taq DNAPolymerase followed by 45 cycles of PCR amplification each
comprising of 95°C for 15 seconds, 55°C for 15 seconds,
and 72°C for 30 seconds. Data collection was done at 72°C
of each cycle. Following amplification, a melting curve
(dissociation curve) analysis was performed to verify the
authenticity of the amplified products by checking their
specific melting temperatures (Tm). In each batch all ref-
erence standards as well as samples were tested in tripli-
cate and appropriate negative as well as reagent controls
were included to exclude the possibility of cross contam-
ination during the setting up of reactions.
Intra- and inter-assay validation
For intra- and inter-assay validation 25 HIV-1 sero-
positive samples were tested 10 times each in different
batches independently and in triplicate including the ref-
erence standards and controls and their coefficient of
variation was calculated.
Sensitivity and specificity
For finding limit of detection of the assay 10, 30, 50, 100
and 500 copies/ml of serially diluted standards were
tested in triplicate in 20 independent experiments. In
order to measure the specificity of the assay all known
HIV-1 sero-negative samples (Table 2) were subjected to
real time PCR amplification followed by comparison of
the melting-temperature data with known positives as
well as no-template control (NTC) samples.
Comparing sensitivity of detection against two
commercial HIV-1 copy number detection assays
A panel of 90 plasma samples which was a part of the study
panel and with HIV-1 viral copy number ranging from
5,000–25,000 HIV-1 RNA copies/mL as estimated using
artus HIV-1 RG RT-PCR kit (Qiagen, Germany) and con-
firmed as sub type C using method described by Siddappa
et al. [15] were simultaneously subjected to quantitative de-
tection of HIV-1 RNA using (a) HIV RNA Real-TM Quant
(Sacace Biotechnologies S.r.l, Italy) (b) HIV-1 Real Time RT
PCR kit (Life River, Shanghai ZJ Biotech, China) and (c)
assay method developed in this study. All RT-PCR reactions
were set in duplicate in two separate thermal cyclers of
identical make (StepOne Plus Real Time PCR System;
Applied Biosystems, USA) in order to minimize the influ-
ence of experimental errors.
Effect of storage time and temperature on stability of
plasma samples
Plasma samples of 10 patients with known viral load
were collected and two aliquots were made from each of
them. One set of plasma were stored at −20°C and the
other at 25°C. RNA was extracted from both set of sam-
ples at day seven and their viral load estimated in tripli-
cate using the method described in this study.
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The linearity of the assay was determined by linear re-
gression method using the MedCalc v.12.7.2 (Acacialaan
22, B-8400 Ostend, Belgium) program. Sensitivity of the
assay was expressed as the percentage of samples that
scored positive using the protocol described in this study
divided by the total number of samples that scored posi-
tive using an US -FDA approved commercial assay. Spe-
cificity of the assay was calculated as the number of
negative samples scored using the present study divided
by the total number of known negative samples obtained
from healthy donors and was expressed in percentage.
Performance of the assay was measured by doing a
comparative analysis with artus HIV-1 RG RT-PCR kit
(Qiagen, Germany) and applying the Spearman correlation
coefficient formula (http://www.wessa.net/rankcorr.wasp).
The effect of ambient temperature on the stability of HIV-1
RNA was analyzed using the Wilcoxon signed rank test
[16] and the box and a whisker plot was created using
BioStat program (AnalystSoft Inc, USA).
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